Related Experiment Video
Updated: May 5, 2026
12:37
Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
12.5K
Natriuretic peptides in unstable coronary artery disease
Tomas Jernberg1, Stefan James, Bertil Lindahl
1Department of Medical Sciences, Cardiology and Uppsala Research Center, Sweden. tomas.jernberg@medsci.uu.se
European Heart Journal
|September 3, 2004
Summary
Natriuretic peptides, such as brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-proBNP), help predict mortality and heart failure risk in unstable coronary artery disease (CAD). Further research is needed for routine clinical use.
Area of Science:
- Cardiology
- Biomarkers
- Clinical Risk Assessment
Background:
- Unstable coronary artery disease (CAD) presents diverse clinical scenarios, necessitating early risk stratification for optimal treatment selection.
- Current risk assessment for unstable CAD relies on established factors, but improved prognostic tools are continually sought.
- Natriuretic peptides are increasingly recognized for their role in cardiovascular assessment.
Purpose of the Study:
- To review the emerging role of natriuretic peptides in the early risk assessment of patients with unstable CAD.
- To evaluate the prognostic value of brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in unstable CAD.
- To explore the potential utility of these biomarkers in guiding therapeutic decisions.
Main Methods:
- Systematic review of current literature on natriuretic peptides in unstable CAD.
- Analysis of studies investigating the association between BNP/NT-proBNP levels and patient outcomes.
- Evaluation of evidence regarding the impact of natriuretic peptides on treatment selection.
Main Results:
- Elevated levels of BNP and NT-proBNP are strongly correlated with mortality risk in unstable CAD patients.
- These natriuretic peptides provide prognostic information independent of traditional risk factors.
- Evidence suggests potential benefits in guiding therapy, though further validation is required.
Conclusions:
- BNP and NT-proBNP are valuable prognostic markers for mortality and heart failure risk in unstable CAD.
- While promising for therapy selection, routine use requires further investigation into cost-effectiveness and clinical impact.
- Additional studies are essential to confirm the role of natriuretic peptides in guiding treatment strategies for unstable CAD.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
769
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
01:30Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
01:30Acute Coronary Syndrome III: Diagnostic Studies
500
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500
01:29Heart Failure II: Pathophysiology
2.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K